New insights into the antiviral effects of chloroquine

[1]  C. Ursic,et al.  Multifocal cutaneous mucormycosis complicating polymicrobial wound infections in a tsunami survivor from Sri Lanka , 2005, The Lancet.

[2]  A. Holmes,et al.  Postgraduate training in infectious diseases: investigating the current status in the international community , 2005, The Lancet Infectious Diseases.

[3]  Stéphane Hugonnet,et al.  Noma: an "infectious" disease of unknown aetiology. , 2003, The Lancet. Infectious diseases.

[4]  T. Tsurumi,et al.  Mechanism of uncoating of influenza B virus in MDCK cells: action of chloroquine. , 1983, The Journal of general virology.

[5]  K. Dimock,et al.  Avian influenza and sialic acid receptors: more than meets the eye? , 2005, The Lancet. Infectious diseases.

[6]  Benjamin A Lipsky,et al.  Diagnosis and treatment of diabetic foot infections. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[7]  J. Lenard,et al.  Antihistaminics, local anesthetics, and other amines as antiviral agents. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[8]  Marc Van Ranst,et al.  In vitro inhibition of severe acute respiratory syndrome coronavirus by chloroquine , 2004, Biochemical and Biophysical Research Communications.

[9]  R. Sawyer,et al.  Aspergillus flavus wound infection following repair of a ruptured duodenum in a non-immunocompromised host. , 1992, Scandinavian journal of infectious diseases.

[10]  Dhanashree S. Kelkar,et al.  Low cost anti-retroviral options: chloroquine based ARV regimen combined with hydroxyurea and lamivudine: a new economical triple therapy. , 2004, The Journal of the Association of Physicians of India.

[11]  N. Seidah,et al.  Chloroquine is a potent inhibitor of SARS coronavirus infection and spread , 2005, Virology Journal.

[12]  F. Pien,et al.  Head and neck cellulitis in hospitalized adults. , 1993, American journal of otolaryngology.

[13]  K. Yeh,et al.  Aspergillus: a rare primary organism in soft-tissue infections. , 1998, The American surgeon.

[14]  P Willett,et al.  Development and validation of a genetic algorithm for flexible docking. , 1997, Journal of molecular biology.

[15]  L. Gettleman,et al.  Posttraumatic invasive Aspergillus fumigatus wound infection. , 1999, The Pediatric infectious disease journal.

[16]  G. Scott,et al.  Primary Cutaneous Mucormycosis: Guide to Surgical Management , 2002, Annals of plastic surgery.

[17]  Sergio Rutella,et al.  Anti-HIV Effects of Chloroquine: Inhibition of Viral Particle Glycosylation and Synergism With Protease Inhibitors , 2004, Journal of acquired immune deficiency syndromes.

[18]  N. Paton,et al.  Hydroxychloroquine, hydroxyurea and didanosine as initial therapy for HIV‐infected patients with low viral load: safety, efficacy and resistance profile after 144 weeks , 2005, HIV medicine.

[19]  R. Webster,et al.  Characterization of H5N2 influenza viruses from Italian poultry. , 2001, The Journal of general virology.

[20]  J. Perfect,et al.  Soft‐Tissue Fungal Infections: Surgical Management of 12 Immunocompromised Patients , 1996, Plastic and reconstructive surgery.

[21]  A. Cassone,et al.  Effects of chloroquine on viral infections: an old drug against today's diseases , 2003, The Lancet Infectious Diseases.

[22]  A. Safdar.  Progressive cutaneous hyalohyphomycosis due to Paecilomyces lilacinus: rapid response to treatment with caspofungin and itraconazole. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[23]  J. Rudolph,et al.  Kinetic mechanism of quinone oxidoreductase 2 and its inhibition by the antimalarial quinolines. , 2004, Biochemistry.

[24]  M. Zayed,et al.  Necrotizing fasciitis of the head and neck: Report of three cases. , 1997, Annals of Saudi medicine.

[25]  D. Vinh,et al.  Rapidly progressive soft tissue infections. , 2005, The Lancet. Infectious diseases.

[26]  J. Lisziewicz,et al.  Optimal suppression of HIV replication by low-dose hydroxyurea through the combination of antiviral and cytostatic (‘virostatic’) mechanisms , 2005, AIDS (London).

[27]  P. Kelley,et al.  Decreases in invasive Haemophilus influenzae diseases in US Army children, 1984 through 1991. , 1993, JAMA.